FDA OKs Risdiplam
A few days ago FDA officially okayed risdiplam (Evrysdi; Genentech) for the treatment of spinal muscular atrophy (SMA) for adults and children not younger than…
A few days ago FDA officially okayed risdiplam (Evrysdi; Genentech) for the treatment of spinal muscular atrophy (SMA) for adults and children not younger than…
Esketamine (Spravato; Janssen) CIII nasal spray is the first FDA-approved antidepressant medication that improves depressive symptoms with the first dose in adults with major depressive…
Pharmacologists can perform a role in the medical payment process for oncology outcomes (aside from other pharmacy operations), which are among the most important of…
Gilead Sciences, Inс has published topline outcomes from the Phase 3 SIMPLE trial in hospitalized sufferers with COVID infection. This open-label research estimated 5-day and…
In Ohio, people with cancer who have several medicine drugs they can no longer use—for example, because their strategic plan or dosage has become—can now…
A current study suggests that improvements to public health policy have to be made sparingly because the chances undermine the future agreement and that the…
The investigation into the nature of inequalities in the gut microbiome has revealed that the combination of gut microbes is connected to human diseases that…
The FDA has awarded a further implication for dapagliflozin (Farxiga, AstraZeneca Pharmaceuticals), heart failure medication, the first sodium-glucose co-transporter 2 (SGLT2) inhibitor to be allowed…
The U.S. Food and Drug Administration recommended Tabrecta (lapatinib) – lung cancer medication against non-small cell lung cancer (NSCLC) that has expanded to other parts…
The analysis from New York University (NYU) Grossman School of Medicine has discovered no link between therapy with four medication classes—angiotensin-converting enzyme (ACE) inhibitors, angiotensin…